Indonesia approves Merck's COVID-19 pill for emergency use
January 14, 2022 / 12:10 PM
Share
Sharjah24 – Reuters: Indonesia has approved Merck & Co Inc's COVID-19 antiviral pill molnupiravir for emergency use, the country's food and drug agency said in a statement.
A batch of 400,000 pills had arrived in Indonesia, health minister Budi Gunadi Sadikin said this week. The pill was jointly developed by U.S.-based Merck and Ridgeback Biotherapeutics.
For an optimal experience, please
